Fresenius Kabi USA Inc (APPX:US)
was acquired by FRE:GR
Fresenius Kabi USA, Inc. develops, manufactures, and markets injectable and specialty pharmaceutical products. The Company specializes in medicines and technologies for infusion, transfusion and clinical nutrition. Fresenius Kabi USA offers its products to hospitals, long-term care facilities, alternative care sites, and clinics around the world.